Stock DHI DR HORTON
Add to a list
To use this feature you must be a member
Log inSign up

DR Horton Stock

Equities

DHI

US23331A1097

Homebuilding

Market Closed - Nyse
Other stock markets
 04:00:02 2025-01-15 pm EST 		5-day change 1st Jan Change
145.41 USD +1.57% Intraday chart for DR Horton +3.94% +4.00%
Jan. 14 Goldman Sachs Adjusts D.R. Horton Price Target to $171 From $200, Maintains Buy Rating MT
Jan. 10 RBC Cuts Price Target on D.R. Horton to $125 From $145, Keeps Underperform Rating MT

Valuation: DR Horton

Capitalization 46.65B 45.32B 42.56B 38.12B 66.86B 4,028B 74.87B 520B 193B 1,654B 175B 171B 7,293B P/E ratio 2025 *
10.4x
P/E ratio 2026 * 9.25x
Enterprise value 48.07B 46.69B 43.85B 39.28B 68.89B 4,151B 77.14B 536B 199B 1,704B 180B 177B 7,514B EV / Sales 2025 *
1.3x
EV / Sales 2026 * 1.21x
Free-Float
72.05%
Yield 2025 *
1.06%
Yield 2026 * 1.13%
More valuation ratios * Estimated data

Chart: DR Horton

Dynamic Chart

Latest news: DR Horton

Goldman Sachs Adjusts D.R. Horton Price Target to $171 From $200, Maintains Buy Rating Jan. 14 MT
RBC Cuts Price Target on D.R. Horton to $125 From $145, Keeps Underperform Rating Jan. 10 MT
UBS Adjusts Price Target on D.R. Horton to $203 From $214, Maintains Buy Rating Jan. 08 MT
Wells Fargo Cuts Price Target on D.R. Horton to $175 From $190, Maintains Overweight Rating Dec. 17 MT
Certain Homebuilders' Gross Margins Seen Under Pressure Heading Into 2025, BofA Says Dec. 16 MT
BofA Securities Cuts Price Target on D.R. Horton to $170 From $190, Maintains Buy Rating Dec. 16 MT
Evercore ISI Adjusts Price Target on D.R. Horton to $212 From $204 Dec. 16 MT
Argus Adjusts Price Target on D.R. Horton to $190 From $200 Dec. 16 MT
US stocks close flat ahead of next week's Fed meeting Dec. 13 RE
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading Dec. 13 MT
Sector Update: Consumer Dec. 13 MT
D.R. Horton Shares Fall After Downgrade From J.P. Morgan Dec. 13 MT
JPMorgan Downgrades D.R. Horton to Underweight From Neutral, Adjusts Price Target to $156 From $188 Dec. 13 MT
More news

Last Transcript: DR Horton

Logo DR Horton
D.R. Horton, Inc., Q4 2024 Earnings Call, Oct 29, 2024
24-10-29
More transcripts

Analysts' recommendations: DR Horton

Goldman Sachs Adjusts D.R. Horton Price Target to $171 From $200, Maintains Buy Rating Jan. 14 MT
RBC Cuts Price Target on D.R. Horton to $125 From $145, Keeps Underperform Rating Jan. 10 MT
UBS Adjusts Price Target on D.R. Horton to $203 From $214, Maintains Buy Rating Jan. 08 MT
Wells Fargo Cuts Price Target on D.R. Horton to $175 From $190, Maintains Overweight Rating Dec. 17 MT
BofA Securities Cuts Price Target on D.R. Horton to $170 From $190, Maintains Buy Rating Dec. 16 MT
More recommendations

Press Releases: DR Horton

DR Horton : 2022 & 2023 EEO-1 Disclosure Dec. 19 PU
D.R. Horton, Inc. to Release 2025 First Quarter Earnings on January 21, 2025 Dec. 03 BU
DR Horton : Q4 FY 2024 Earnings Call Transcript 24-10-30 PU
DR Horton : Amendment to Initial Statement of Beneficial Ownership - Form 3/A 24-10-30 PU
DR Horton : D.R. HORTON, INC., AMERICA’S BUILDER, REPORTS FOURTH QUARTER AND FISCAL 2024 EARNINGS AND INCREASES QUARTERLY DIVIDEND TO $0.40 PER SHARE Form 8 K 24-10-29 PU
More press releases

News in other languages: DR Horton

DR Horton : en chute après ses trimestriels 24-10-29
Wall Street compte les points présidentiels en attendant Alphabet 24-10-29
En Direct des Marchés : Vivendi, Vinci, Novartis, Adidas, VusionGroup, HSBC, Spie, Ford... 24-10-29
MÄRKTE USA/Fester - Starke Payrolls lindern Konjunktursorgen 24-10-04
ETF de la semana: La defensa vuelve a estar en el punto de mira 24-10-03
More news

Quotes and Performance

1 day+0.13%
1 week+5.49%
Current month+4.00%
1 month-2.98%
3 months-22.29%
6 months-5.42%
Current year+4.00%
More quotes

Course Extremes

1 week
136.23
Extreme 136.23
149.95
1 month
135.00
Extreme 135.0033
152.15
Current year
136.23
Extreme 136.23
149.95
1 year
133.02
Extreme 133.02
199.85
3 years
59.25
Extreme 59.25
199.85
5 years
25.51
Extreme 25.51
199.85
10 years
22.12
Extreme 22.1199
199.85
More quotes

Managers and Directors: DR Horton

Director TitleAgeSince
Paul Romanowski CEO
 Chief Executive Officer 55 2023-09-30
Bill Wheat DFI
 Director of Finance/CFO 59 2002-12-31
Michael Murray COO
 Chief Operating Officer 59 2014-10-02
Manager TitleAgeSince
Michael Buchanan BRD
 Director/Board Member 78 2003-10-31
Bradley Anderson BRD
 Director/Board Member 64 1998-03-31
David Auld CHM
 Chairman 69 2024-05-16
More insiders

ETFs: DR Horton

Name Weight AuM 1st Jan change Investor Rating
MERLYN.AI BULL-RIDER BEAR-FIGHTER ETF - USD ETF Merlyn.AI Bull-Rider Bear-Fighter ETF - USD
3.30% 0 M€ -1.62% -
JPMORGAN SOCIAL ADVANCEMENT ETF - USD ETF JPMorgan Social Advancement ETF - USD
1.77% 0 M€ +15.09% -
STERLING CAPITAL DIVERSE MULTI-MANAGER ACTIVE ETF- USD ETF Sterling Capital Diverse Multi-Manager Active ETF- USD
1.33% 0 M€ +0.06% -
More ETFs: DR Horton

Other Homebuilding

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
DR HORTON Stock DR Horton
+1.57%+5.49%-5.53%+47.58%45.93B
PULTEGROUP, INC. Stock PulteGroup, Inc.
+3.08%+7.55%+10.54%+103.14%23.07B
DAIWA HOUSE INDUSTRY CO., LTD. Stock Daiwa House Industry Co., Ltd.
-0.32%-3.21%+2.57%+38.45%18.82B
SEKISUI HOUSE, LTD. Stock Sekisui House, Ltd.
-0.28%-4.58%+8.09%+48.92%14.72B
TOLL BROTHERS, INC. Stock Toll Brothers, Inc.
+2.54%+8.37%+32.48%+102.03%13.09B
BARRATT REDROW PLC Stock Barratt Redrow plc
+4.42%+0.14%-22.26%-37.91%7.09B
SEKISUI CHEMICAL CO., LTD. Stock Sekisui Chemical Co., Ltd.
-0.82%-6.60%+15.80%+28.09%6.62B
SUMITOMO FORESTRY CO., LTD. Stock Sumitomo Forestry Co., Ltd.
-2.30%-4.53%+10.44%+133.55%6.59B
TAYLOR MORRISON HOME CORPORATION Stock Taylor Morrison Home Corporation
+3.32%+9.02%+26.23%+99.48%6.55B
PIK-SPECIALIZED HOMEBUILDER Stock PIK-specialized homebuilder
+0.01%-.--%-.--%-38.03%4.85B
Average +0.98%+0.20%+7.84%+52.53% 14.73B
Weighted average by Cap. +0.90%+1.33%+5.22%+58.43%
See all sector performances

Financials

2025 *2026 *
Net sales 37.09B 36.03B 33.84B 30.31B 53.16B 3,203B 59.53B 413B 153B 1,315B 139B 136B 5,798B 39.72B 38.59B 36.24B 32.46B 56.93B 3,430B 63.75B 443B 164B 1,409B 149B 146B 6,210B
Net income 4.47B 4.34B 4.08B 3.65B 6.4B 386B 7.17B 49.79B 18.47B 158B 16.76B 16.41B 698B 4.87B 4.73B 4.44B 3.98B 6.98B 421B 7.82B 54.3B 20.15B 173B 18.28B 17.89B 762B
Net Debt 1.42B 1.38B 1.29B 1.16B 2.03B 122B 2.27B 15.78B 5.85B 50.2B 5.31B 5.2B 221B 1.53B 1.48B 1.39B 1.25B 2.19B 132B 2.45B 17.03B 6.32B 54.18B 5.73B 5.61B 239B
More financial data * Estimated data

Company Profile

Logo DR Horton
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (93.3%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (4.4%); - supply of financial services (2.3%).
Employees
14,766
Sector
Homebuilding
Calendar
2025-01-15 - Annual General Meeting
More about the company

Quotes

Date Price Change Volume
25-01-15 145.41 $ +1.57% 4,308,162
25-01-14 143.16 $ +3.44% 3,405,421
25-01-13 138.40 $ +1.38% 3,526,161
25-01-10 136.52 $ -2.42% 3,523,432
25-01-08 139.90 $ +1.49% 3,067,796

Delayed Quote Nyse, January 15, 2025 at 04:00 pm EST

More quotes

Income Statement and Estimates

income-statement-evolution-chart DR-HORTON More financial data

Ratings

Trading Rating
Investor Rating
ESG MSCI
A
surperformance-ratings-light-chart DR-HORTONMore Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
143.16USD
Average target price
175.10USD
Spread / Average Target
+22.31%
Consensus
Profit revisions
estimates-change-chart DR-HORTON Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart DR-HORTON Company calendar
  1. Stock Market
  2. Equities
  3. DHI Stock